<DOC>
	<DOCNO>NCT01401595</DOCNO>
	<brief_summary>The purpose study determine effectiveness anti-depressant Lexapro treatment Night Eating Syndrome .</brief_summary>
	<brief_title>Brain Imaging Treatment Studies Night Eating Syndrome</brief_title>
	<detailed_description>This proposal explore implication two recent major discovery : strike efficacy Selective Serotonin Reuptake Inhibitor ( SSRI ) sertraline control Night Eating Syndrome ( NES ) unprecedented elevation level serotonin transporter ( SERT ) bind midbrain person NES . Our overall theory NES associate syndrome-specific increase SERT derive genetic vulnerability affect life stress . This increase SERT activity produce fall post-synaptic serotonin level . The investigator hypothesize decrease serotonin level result significant phase delay circadian food intake manifest even hyperphagia , nighttime ingestion morning anorexia . SSRIs block increase SERT activity increase synaptic serotonin level restore circadian rhythm food intake .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<criteria>men woman suffer NES age 18 70 year BMI great 18.5 kg/m2 Children adolescent &lt; 18 year person older 70 patient diabetes mellitus thyroid disease endocrine metabolic disorder use within past month psychotropic medication , oral steroid , diuretic hypnotic current anorexia nervosa bulimia nervosa participation organize weight reduction program use antiobesity medication occupation involve night shift unusual time requirement Major Depressive Disorder ( judge severe ) Bipolar Disorder suicidal risk current past psychosis substance use abuse disorder within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>